Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

Pathological mechanisms in progressive multiple sclerosis

(2015) Don H Mahad et al.   LANCET NEUROLOGY

Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis

(2014) R. Ratzer et al.   JOURNAL OF NEUROIMMUNOLOGY

Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial

(2014) J. Romme Christensen et al.   NEUROLOGY

Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity

(2013) Levente Szalardy et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Disease-modifying treatments for progressive multiple sclerosis

(2013) Giancarlo Comi   Multiple Sclerosis Journal

Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

(2013) Jeppe Romme Christensen et al.   PLoS One

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

(2012) Jeppe Romme Christensen et al.   Multiple Sclerosis Journal

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis

(2010) Lars Börnsen et al.   Multiple Sclerosis Journal

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY